Exploris Health AG is a pioneering company specializing in artificial intelligence-based diagnostics and therapy solutions in the medical equipment manufacturing sector. Founded in 2018, the company is headquartered in Wallisellen, Zürich, Switzerland.

Exploris Health harnesses artificial intelligence to develop precise, non-invasive tests that accelerate accurate diagnoses and improve treatment outcomes. Their solutions include advanced AI platforms for data science and predictive modeling, and innovative diagnostics such as the Cardio Explorer, a non-invasive test designed to detect life-threatening narrowing of the coronary arteries— the main cause of heart attacks. The company also offers personalized therapy solutions for heart failure, empowering patient self-treatment and therapy optimization.

Exploris Health is committed to enhancing cardiovascular health through cutting-edge digital biomarkers, machine learning, and software as a medical device (SaMD). Their solutions promote early detection, personalized treatment, and improved patient safety.

The company has received several prestigious awards, including the InsureNXT Innovation Award and the DMEA nova Award 2024, recognizing their impact on digital health and preventive cardiology diagnostics.

Exploris Health collaborates with leading partners such as Microsoft, Roche, University Hospital Basel, Preventon, and others to advance healthcare innovation.